Article
Metabolite Genome-Wide Association Study for Indoleamine 2,3-Dioxygenase Activity Associated with Chronic Kidney Disease.
Genes - 27 Nov 2021
Kim Hye-Rim, Jin Hyun-Seok, Eom Yong-Bin
Abstract excerpt
Chronic kidney disease (CKD) causes progressive damage to kidney function with increased inflammation. This process contributes to complex amino acid changes. Indoleamine 2,3-dioxygenase (IDO) has been proposed as a new biomarker of CKD in previous studies. In our research, we performed a metabolite genome-wide association study (mGWAS) to identify common and rare variants associated with IDO activity in a Korean...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
